MONOGENIC OBESITY (MOB)

Clinical trials for MONOGENIC OBESITY (MOB) explained in plain language.

Never miss a new study

Get alerted when new MONOGENIC OBESITY (MOB) trials appear

Sign up with your email to follow new studies for MONOGENIC OBESITY (MOB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Special access opens for rare metabolic and obesity disorders

Disease control AVAILABLE

This program provides special access to an investigational drug called REGN4461 for patients with rare diseases where the body's leptin signaling is deficient. It is for conditions like lipodystrophy (abnormal fat distribution) and monogenic obesity (a genetic form of obesity). A…

Matched conditions: MONOGENIC OBESITY (MOB)

Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

MONOGENIC OBESITY (MOB)

Get alerted when new MONOGENIC OBESITY (MOB) trials appear

Special access opens for rare metabolic and obesity disorders